Last 12 months
Inside the activity.
5 purchase rows · 15 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 5 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 11 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 4 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 02, 2026 Filed Jan 6, 2026 16:00 UTC |
Kiener Peter ADirector
|
GrantStock Option (right to buy) · Derivative | 24,400 | $0.00 Strike: $0.34 | $0.00 |
DisclosureSEC source: 0001193125-26-004359 · ownership.xml · derivative · entry 1 Kiener Peter A · CIK 0001328146 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,400 Underlying: Common Stock · 24,400 shares Expires 2036-01-01 F1 · shares: Represents a stock option award granted pursuant to the Issuer's Director Compensation Policy. F2 · derivative.exercise_date: This stock option becomes fully exercisable on the first anniversary of the grant date. Read SEC document |
| January 02, 2026 Filed Jan 6, 2026 21:00 UTC |
Garzone PamelaDirector
|
GrantStock Option (right to buy) · Derivative | 24,400 | $0.00 Strike: $0.34 | $0.00 |
DisclosureSEC source: 0001193125-26-004356 · ownership.xml · derivative · entry 1 Garzone Pamela · CIK 0001974756 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,400 Underlying: Common Stock · 24,400 shares Expires 2036-01-01 F1 · shares: Represents a stock option award granted pursuant to the Issuer's Director Compensation Policy. F2 · derivative.exercise_date: This stock option becomes fully exercisable on the first anniversary of the grant date. Read SEC document |
| January 02, 2026 Filed Jan 6, 2026 21:00 UTC |
Morich FrankDirector
|
GrantStock Option (right to buy) · Derivative | 24,400 | $0.00 Strike: $0.34 | $0.00 |
DisclosureSEC source: 0001193125-26-004357 · ownership.xml · derivative · entry 1 Morich Frank · CIK 0001748615 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,400 Underlying: Common Stock · 24,400 shares Expires 2036-01-01 F1 · shares: Represents a stock option award granted pursuant to the Issuer's Director Compensation Policy. F2 · derivative.exercise_date: This stock option becomes fully exercisable on the first anniversary of the grant date. Read SEC document |
| January 02, 2026 Filed Jan 6, 2026 21:00 UTC |
Verheyen PatrickDirector
|
GrantStock Option (right to buy) · Derivative | 24,400 | $0.00 Strike: $0.34 | $0.00 |
DisclosureSEC source: 0001193125-26-004355 · ownership.xml · derivative · entry 1 Verheyen Patrick · CIK 0001972605 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,400 Underlying: Common Stock · 24,400 shares Expires 2036-01-01 F1 · shares: Represents a stock option award granted pursuant to the Issuer's Director Compensation Policy. F2 · derivative.exercise_date: This stock option becomes fully exercisable on the first anniversary of the grant date. Read SEC document |
| December 30, 2025 Filed Jan 2, 2026 16:00 UTC |
Sarraf PashaDirector
|
PurchaseCommon Stock | 77,417 | $0.30 | $23,348.97 |
DisclosureSEC source: 0001193125-26-000900 · ownership.xml · nonDerivative · entry 5 Sarraf Pasha · CIK 0002059447 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 323,857 Read SEC document |
| December 30, 2025 Filed Jan 2, 2026 16:00 UTC |
Sarraf PashaDirector
|
PurchaseCommon Stock | 78,116 | $0.31 | $24,325.32 |
DisclosureSEC source: 0001193125-26-000900 · ownership.xml · nonDerivative · entry 4 Sarraf Pasha · CIK 0002059447 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 246,440 Read SEC document |
| December 30, 2025 Filed Jan 2, 2026 16:00 UTC |
Sarraf PashaDirector
|
PurchaseCommon Stock | 86,947 | $0.32 | $27,596.98 |
DisclosureSEC source: 0001193125-26-000900 · ownership.xml · nonDerivative · entry 3 Sarraf Pasha · CIK 0002059447 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 168,324 Read SEC document |
| December 30, 2025 Filed Jan 2, 2026 16:00 UTC |
Sarraf PashaDirector
|
PurchaseCommon Stock | 77,148 | $0.30 | $23,167.54 |
DisclosureSEC source: 0001193125-26-000900 · ownership.xml · nonDerivative · entry 2 Sarraf Pasha · CIK 0002059447 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 81,377 Read SEC document |
| December 30, 2025 Filed Jan 2, 2026 16:00 UTC |
Sarraf PashaDirector
|
PurchaseCommon Stock | 4,229 | $0.31 | $1,308.45 |
DisclosureSEC source: 0001193125-26-000900 · ownership.xml · nonDerivative · entry 1 Sarraf Pasha · CIK 0002059447 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,229 Read SEC document |
| December 03, 2025 Filed Dec 5, 2025 23:54 UTC |
Sandercock ColinSVP, GENERAL COUNSEL
|
GrantStock Option (right to buy) · Derivative | 70,000 | $0.00 Strike: $0.70 | $0.00 |
DisclosureSEC source: 0001193125-25-310067 · ownership.xml · derivative · entry 2 Sandercock Colin · CIK 0001724870 · SVP, GENERAL COUNSEL 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 70,000 Underlying: Common Stock · 70,000 shares Expires 2024-07-23 F2 · derivative.exercise_date: On July 24, 2024 the Reporting Person was granted an option with vesting subject to the satisfaction of performance-based vesting criteria. The performance-based vesting criteria for these shares was deemed satisfied or waived on December 3, 2025 and these shares underlying the option vested. Read SEC document |
| September 29, 2025 Filed Oct 3, 2025 00:13 UTC |
Azam UsmanDirector · CHIEF EXECUTIVE OFFICER
|
GrantStock Option (right to buy) · Derivative | 1,875,000 | $0.00 Strike: $0.72 | $0.00 |
DisclosureSEC source: 0001193125-25-228920 · ownership.xml · derivative · entry 1 Azam Usman · CIK 0002089768 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,875,000 Underlying: Common Stock · 1,875,000 shares Expires 2035-09-28 F1 · derivative.exercise_date: This stock option becomes exercisable in 48 monthly installments beginning on September 29, 2026. Read SEC document |
| September 29, 2025 Filed Nov 25, 2025 21:00 UTC |
Baker Daniel G.CHIEF DEVELOPMENT OFFICER
|
GrantStock Option (right to buy) · Derivative | 50,000 | $0.00 Strike: $0.72 | $0.00 |
DisclosureSEC source: 0001193125-25-296985 · ownership.xml · derivative · entry 1 Baker Daniel G. · CIK 0002046802 · CHIEF DEVELOPMENT OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2035-09-28 F1 · derivative.exercise_date: This stock option becomes fully exercisable on the first anniversary of the grant date. Read SEC document |
| September 29, 2025 Filed Nov 25, 2025 21:00 UTC |
Warren LucindaCHIEF BUSINESS OFFICER
|
GrantStock Option (right to buy) · Derivative | 125,000 | $0.00 Strike: $0.72 | $0.00 |
DisclosureSEC source: 0001193125-25-296986 · ownership.xml · derivative · entry 1 Warren Lucinda · CIK 0002035620 · CHIEF BUSINESS OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 125,000 Underlying: Common Stock · 125,000 shares Expires 2035-09-28 F1 · derivative.exercise_date: This stock option becomes fully exercisable on the first anniversary of the grant date. Read SEC document |
| September 26, 2025 Filed Dec 5, 2025 23:54 UTC |
Sandercock ColinSVP, GENERAL COUNSEL
|
GrantStock Option (right to buy) · Derivative | 30,000 | $0.00 Strike: $0.70 | $0.00 |
DisclosureSEC source: 0001193125-25-310067 · ownership.xml · derivative · entry 1 Sandercock Colin · CIK 0001724870 · SVP, GENERAL COUNSEL 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 30,000 shares Expires 2034-07-23 F1 · derivative.exercise_date: On July 24, 2024 the Reporting Person was granted an option with vesting subject to the satisfaction of performance-based vesting criteria. The performance-based vesting criteria for these shares was deemed satisfied or waived on September 26, 2025 and these shares underlying the option vested. Read SEC document |
| June 04, 2025 Filed Jun 6, 2025 20:00 UTC |
Broadfoot Jill MarieDirector
|
GrantStock Option (right to buy) · Derivative | 48,800 | $0.00 Strike: $0.62 | $0.00 |
DisclosureSEC source: 0000950170-25-083026 · ownership.xml · derivative · entry 1 Broadfoot Jill Marie · CIK 0001305178 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 48,800 Underlying: Common Stock · 48,800 shares Expires 2035-06-03 F1 · shares: Represents a stock option award granted pursuant to the Issuer's Director Compensation Policy. F2 · derivative.exercise_date: This option was granted on June 4, 2025. The shares underlying the option are scheduled to vest over three years with one-third vesting on the one-year anniversary of the grant date and the balance vesting in eight equal quarterly installments. Read SEC document |
| March 21, 2025 Filed Mar 25, 2025 20:00 UTC |
Baker Daniel G.CHIEF DEVELOPMENT OFFICER
|
GrantStock Option (right to buy) · Derivative | 100,000 | $0.00 Strike: $0.99 | $0.00 |
DisclosureSEC source: 0000950170-25-044346 · ownership.xml · derivative · entry 1 Baker Daniel G. · CIK 0002046802 · CHIEF DEVELOPMENT OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2035-03-20 F1 · derivative.exercise_date: This stock option becomes exercisable in eight equal semi-annual installments beginning on September 21, 2025. Read SEC document |
| March 21, 2025 Filed Mar 25, 2025 20:00 UTC |
Warren LucindaCHIEF BUSINESS OFFICER
|
GrantStock Option (right to buy) · Derivative | 250,000 | $0.00 Strike: $0.99 | $0.00 |
DisclosureSEC source: 0000950170-25-044344 · ownership.xml · derivative · entry 1 Warren Lucinda · CIK 0002035620 · CHIEF BUSINESS OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 250,000 Underlying: Common Stock · 250,000 shares Expires 2035-03-20 F1 · derivative.exercise_date: This stock option becomes exercisable in eight equal semi-annual installments beginning on September 21, 2025. Read SEC document |
| March 21, 2025 Filed Mar 25, 2025 20:00 UTC |
Sandercock ColinSVP, GENERAL COUNSEL
|
GrantStock Option (right to buy) · Derivative | 200,000 | $0.00 Strike: $0.99 | $0.00 |
DisclosureSEC source: 0000950170-25-044345 · ownership.xml · derivative · entry 1 Sandercock Colin · CIK 0001724870 · SVP, GENERAL COUNSEL 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 200,000 Underlying: Common Stock · 200,000 shares Expires 2035-03-20 F1 · derivative.exercise_date: This stock option becomes exercisable in eight equal semi-annual installments beginning on September 21, 2025. Read SEC document |
| March 21, 2025 Filed Mar 25, 2025 16:00 UTC |
PASSERI DANIEL RDirector · CHIEF EXECUTIVE OFFICER
|
GrantStock Option (right to buy) · Derivative | 450,000 | $0.00 Strike: $0.99 | $0.00 |
DisclosureSEC source: 0000950170-25-044347 · ownership.xml · derivative · entry 1 PASSERI DANIEL R · CIK 0001190121 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 450,000 Underlying: Common Stock · 450,000 shares Expires 2035-03-20 F1 · derivative.exercise_date: This stock option becomes exercisable in eight equal semi-annual installments beginning on September 21, 2025. Read SEC document |
| March 21, 2025 Filed Mar 25, 2025 20:00 UTC |
Millar Kerri-AnnCHIEF FINANCIAL OFFICER
|
GrantStock Option (right to buy) · Derivative | 200,000 | $0.00 Strike: $0.99 | $0.00 |
DisclosureSEC source: 0000950170-25-044348 · ownership.xml · derivative · entry 1 Millar Kerri-Ann · CIK 0001739126 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 200,000 Underlying: Common Stock · 200,000 shares Expires 2035-03-20 F1 · derivative.exercise_date: This stock option becomes exercisable in eight equal semi-annual installments beginning on September 21, 2025. Read SEC document |
| March 21, 2025 Filed Mar 25, 2025 20:00 UTC |
Levisetti MatteoChief Medical Officer
|
GrantStock Option (right to buy) · Derivative | 250,000 | $0.00 Strike: $0.99 | $0.00 |
DisclosureSEC source: 0000950170-25-044343 · ownership.xml · derivative · entry 1 Levisetti Matteo · CIK 0001962444 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 250,000 Underlying: Common Stock · 250,000 shares Expires 2035-03-20 F1 · derivative.exercise_date: This stock option becomes exercisable in eight equal semi-annual installments beginning on September 21, 2025. Read SEC document |
| March 10, 2025 Filed Mar 12, 2025 16:00 UTC |
Sarraf PashaDirector
|
GrantStock Option (right to buy) · Derivative | 48,800 | $0.00 Strike: $1.03 | $0.00 |
DisclosureSEC source: 0000950170-25-037889 · ownership.xml · derivative · entry 1 Sarraf Pasha · CIK 0002059447 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 48,800 Underlying: Common Stock · 48,800 shares Expires 2035-03-09 F1 · shares: Represents a stock option award granted pursuant to the Issuer's Director Compensation Policy. F2 · derivative.exercise_date: This option was granted on March 10, 2025. The shares underlying the option are scheduled to vest over three years with one-third vesting on the one-year anniversary of the grant date and the balance vesting in eight equal quarterly installments. Read SEC document |
| January 02, 2025 Filed Jan 3, 2025 21:00 UTC |
DRISCOLL FREDERICK WDirector
|
GrantStock Option (right to buy) · Derivative | 24,400 | $0.00 Strike: $1.09 | $0.00 |
DisclosureSEC source: 0000950170-25-001106 · ownership.xml · derivative · entry 1 DRISCOLL FREDERICK W · CIK 0001129890 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,400 Underlying: Common Stock · 24,400 shares Expires 2035-01-01 F1 · shares: Represents a stock option award granted pursuant to the Issuer's Director Compensation Policy. F2 · derivative.exercise_date: This option was granted on January 2, 2025. The option is scheduled to vest as to 50% of the underlying shares on the six-month anniversary of the grant date and as to the remaining 50% on the first anniversary of the grant date. Read SEC document |
| January 02, 2025 Filed Jan 3, 2025 16:00 UTC |
Kiener Peter ADirector
|
GrantStock Option (right to buy) · Derivative | 24,400 | $0.00 Strike: $1.09 | $0.00 |
DisclosureSEC source: 0000950170-25-001105 · ownership.xml · derivative · entry 1 Kiener Peter A · CIK 0001328146 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,400 Underlying: Common Stock · 24,400 shares Expires 2035-01-01 F1 · shares: Represents a stock option award granted pursuant to the Issuer's Director Compensation Policy. F2 · derivative.exercise_date: This option was granted on January 2, 2025. The option is scheduled to vest as to 50% of the underlying shares on the six-month anniversary of the grant date and as to the remaining 50% on the first anniversary of the grant date. Read SEC document |
| January 02, 2025 Filed Jan 3, 2025 21:00 UTC |
Verheyen PatrickDirector
|
GrantStock Option (right to buy) · Derivative | 24,400 | $0.00 Strike: $1.09 | $0.00 |
DisclosureSEC source: 0000950170-25-001103 · ownership.xml · derivative · entry 1 Verheyen Patrick · CIK 0001972605 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,400 Underlying: Common Stock · 24,400 shares Expires 2035-01-01 F1 · shares: Represents a stock option award granted pursuant to the Issuer's Director Compensation Policy. F2 · derivative.exercise_date: This option was granted on January 2, 2025. The option is scheduled to vest as to 50% of the underlying shares on the six-month anniversary of the grant date and as to the remaining 50% on the first anniversary of the grant date. Read SEC document |
| January 02, 2025 Filed Jan 3, 2025 21:00 UTC |
Garzone PamelaDirector
|
GrantStock Option (right to buy) · Derivative | 24,400 | $0.00 Strike: $1.09 | $0.00 |
DisclosureSEC source: 0000950170-25-001101 · ownership.xml · derivative · entry 1 Garzone Pamela · CIK 0001974756 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,400 Underlying: Common Stock · 24,400 shares Expires 2035-01-01 F1 · shares: Represents a stock option award granted pursuant to the Issuer's Director Compensation Policy. F2 · derivative.exercise_date: This option was granted on January 2, 2025. The option is scheduled to vest as to 50% of the underlying shares on the six-month anniversary of the grant date and as to the remaining 50% on the first anniversary of the grant date. Read SEC document |
| January 02, 2025 Filed Jan 3, 2025 21:00 UTC |
Morich FrankDirector
|
GrantStock Option (right to buy) · Derivative | 24,400 | $0.00 Strike: $1.09 | $0.00 |
DisclosureSEC source: 0000950170-25-001107 · ownership.xml · derivative · entry 1 Morich Frank · CIK 0001748615 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,400 Underlying: Common Stock · 24,400 shares Expires 2035-01-01 F1 · shares: Represents a stock option award granted pursuant to the Issuer's Director Compensation Policy. F2 · derivative.exercise_date: This option was granted on January 2, 2025. The option is scheduled to vest as to 50% of the underlying shares on the six-month anniversary of the grant date and as to the remaining 50% on the first anniversary of the grant date. Read SEC document |
| December 16, 2024 Filed Dec 18, 2024 16:00 UTC |
PASSERI DANIEL RDirector · CHIEF EXECUTIVE OFFICER
|
PurchaseCommon Stock | 30,000 | $1.03 | $30,900.00 |
DisclosureSEC source: 0000950170-24-137860 · ownership.xml · nonDerivative · entry 1 PASSERI DANIEL R · CIK 0001190121 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 164,578 F1 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.97 to $1.04, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range provided. Read SEC document |
| November 25, 2024 Filed Nov 29, 2024 21:00 UTC |
Baker Daniel G.CHIEF DEVELOPMENT OFFICER
|
GrantStock Option (right to buy) · Derivative | 200,000 | $0.00 Strike: $1.06 | $0.00 |
DisclosureSEC source: 0000950170-24-131890 · ownership.xml · derivative · entry 1 Baker Daniel G. · CIK 0002046802 · CHIEF DEVELOPMENT OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 200,000 Underlying: Common Stock · 200,000 shares Expires 2034-11-24 F1 · shares: Represents an inducement stock option granted on November 25, 2024. F2 · derivative.exercise_date: This stock option will become exercisable over two years in equal, semi-annual installments beginning on May 25, 2025. Read SEC document |
| September 03, 2024 Filed Sep 5, 2024 20:00 UTC |
Warren LucindaCHIEF BUSINESS OFFICER
|
GrantStock Option (right to buy) · Derivative | 350,000 | $0.00 Strike: $0.66 | $0.00 |
DisclosureSEC source: 0000950170-24-103955 · ownership.xml · derivative · entry 1 Warren Lucinda · CIK 0002035620 · CHIEF BUSINESS OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 350,000 Underlying: Common Stock · 350,000 shares Expires 2034-09-02 F1 · derivative.exercise_date: This stock option becomes exercisable in four equal semi-annual installments beginning on March 3, 2025. Read SEC document |
| June 05, 2024 Filed Jun 7, 2024 20:00 UTC |
Sandercock ColinSVP, GENERAL COUNSEL
|
GrantStock Option (right to buy) · Derivative | 60,000 | $0.00 Strike: $1.65 | $0.00 |
DisclosureSEC source: 0000950170-24-070562 · ownership.xml · derivative · entry 1 Sandercock Colin · CIK 0001724870 · SVP, GENERAL COUNSEL 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 60,000 Underlying: Common Stock · 60,000 shares Expires 2034-06-04 F1 · derivative.exercise_date: This stock option becomes exercisable in eight equal semi-annual installments beginning on December 5, 2024. Read SEC document |
| June 05, 2024 Filed Jun 7, 2024 16:00 UTC |
Fox Michael JDirector
|
GrantStock Option (right to buy) · Derivative | 48,800 | $0.00 Strike: $1.65 | $0.00 |
DisclosureSEC source: 0000950170-24-070563 · ownership.xml · derivative · entry 1 Fox Michael J · CIK 0001589232 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 48,800 Underlying: Common Stock · 48,800 shares Expires 2034-06-04 F1 · shares: Represents a stock option award granted pursuant to the Issuer's Director Compensation Policy. F2 · derivative.exercise_date: This option was granted on June 5, 2024. The shares underlying the option are scheduled to vest over three years with one-third vesting on the one-year anniversary of the grant date and the balance vesting in eight equal quarterly installments Read SEC document |
| June 05, 2024 Filed Jun 7, 2024 20:00 UTC |
Levisetti MatteoChief Medical Officer
|
GrantStock Option (right to buy) · Derivative | 125,000 | $0.00 Strike: $1.65 | $0.00 |
DisclosureSEC source: 0000950170-24-070565 · ownership.xml · derivative · entry 1 Levisetti Matteo · CIK 0001962444 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 125,000 Underlying: Common Stock · 125,000 shares Expires 2034-06-04 F1 · derivative.exercise_date: This stock option becomes exercisable in eight equal semi-annual installments beginning on December 5, 2024. Read SEC document |
| June 05, 2024 Filed Jun 7, 2024 20:00 UTC |
Suri AnishPRESIDENT AND CSO
|
GrantStock Option (right to buy) · Derivative | 150,000 | $0.00 Strike: $1.65 | $0.00 |
DisclosureSEC source: 0000950170-24-070564 · ownership.xml · derivative · entry 1 Suri Anish · CIK 0001739130 · PRESIDENT AND CSO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 150,000 Underlying: Common Stock · 150,000 shares Expires 2034-06-04 F1 · derivative.exercise_date: This stock option becomes exercisable in eight equal semi-annual installments beginning on December 5, 2024. Read SEC document |
| June 05, 2024 Filed Jun 7, 2024 20:00 UTC |
Millar Kerri-AnnCHIEF FINANCIAL OFFICER
|
GrantStock Option (right to buy) · Derivative | 60,000 | $0.00 Strike: $1.65 | $0.00 |
DisclosureSEC source: 0000950170-24-070559 · ownership.xml · derivative · entry 1 Millar Kerri-Ann · CIK 0001739126 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 60,000 Underlying: Common Stock · 60,000 shares Expires 2034-06-04 F1 · derivative.exercise_date: This stock option becomes exercisable in eight equal semi-annual installments beginning on December 5, 2024. Read SEC document |
| March 06, 2024 Filed Mar 8, 2024 21:00 UTC |
Sandercock ColinSVP, GENERAL COUNSEL
|
GrantStock Option (right to buy) · Derivative | 175,000 | $0.00 Strike: $1.94 | $0.00 |
DisclosureSEC source: 0000950170-24-028613 · ownership.xml · derivative · entry 1 Sandercock Colin · CIK 0001724870 · SVP, GENERAL COUNSEL 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 175,000 Underlying: Common Stock · 175,000 shares Expires 2034-03-05 F1 · derivative.exercise_date: This stock option becomes exercisable in eight equal semi-annual installments beginning on September 6, 2024. Read SEC document |
| March 06, 2024 Filed Mar 8, 2024 16:00 UTC |
PASSERI DANIEL RDirector · CHIEF EXECUTIVE OFFICER
|
GrantStock Option (right to buy) · Derivative | 400,000 | $0.00 Strike: $1.94 | $0.00 |
DisclosureSEC source: 0000950170-24-028609 · ownership.xml · derivative · entry 1 PASSERI DANIEL R · CIK 0001190121 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 400,000 Underlying: Common Stock · 400,000 shares Expires 2034-03-05 F1 · derivative.exercise_date: This stock option becomes exercisable in eight equal semi-annual installments beginning on September 6, 2024. Read SEC document |
| March 06, 2024 Filed Mar 8, 2024 21:00 UTC |
Suri AnishPRESIDENT AND CSO
|
GrantStock Option (right to buy) · Derivative | 300,000 | $0.00 Strike: $1.94 | $0.00 |
DisclosureSEC source: 0000950170-24-028611 · ownership.xml · derivative · entry 1 Suri Anish · CIK 0001739130 · PRESIDENT AND CSO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 300,000 Underlying: Common Stock · 300,000 shares Expires 2034-03-05 F1 · derivative.exercise_date: This stock option becomes exercisable in eight equal semi-annual installments beginning on September 6, 2024. Read SEC document |
| March 06, 2024 Filed Mar 8, 2024 21:00 UTC |
Millar Kerri-AnnCHIEF FINANCIAL OFFICER
|
GrantStock Option (right to buy) · Derivative | 250,000 | $0.00 Strike: $1.94 | $0.00 |
DisclosureSEC source: 0000950170-24-028612 · ownership.xml · derivative · entry 1 Millar Kerri-Ann · CIK 0001739126 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 250,000 Underlying: Common Stock · 250,000 shares Expires 2034-03-05 F1 · derivative.exercise_date: This stock option becomes exercisable in eight equal semi-annual installments beginning on September 6, 2024. Read SEC document |
| March 06, 2024 Filed Mar 8, 2024 21:00 UTC |
Levisetti MatteoChief Medical Officer
|
GrantStock Option (right to buy) · Derivative | 260,000 | $0.00 Strike: $1.94 | $0.00 |
DisclosureSEC source: 0000950170-24-028608 · ownership.xml · derivative · entry 1 Levisetti Matteo · CIK 0001962444 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 260,000 Underlying: Common Stock · 260,000 shares Expires 2034-03-05 F1 · derivative.exercise_date: This stock option becomes exercisable in eight equal semi-annual installments beginning on September 6, 2024. Read SEC document |
| February 20, 2024 Filed Feb 22, 2024 21:00 UTC |
Levisetti MatteoChief Medical Officer
|
GrantStock Option (right to buy) · Derivative | 25,000 | $0.00 Strike: $3.36 | $0.00 |
DisclosureSEC source: 0000950170-24-018724 · ownership.xml · derivative · entry 1 Levisetti Matteo · CIK 0001962444 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2033-01-16 F1 · derivative.exercise_date: On January 17, 2023 the Reporting Person was granted an option with vesting subject to the satisfaction of performance-based vesting criteria. The performance-based vesting criteria was deemed satisfied or waived on February 20, 2024 and these shares underlying the option vested in full. Read SEC document |
| January 02, 2024 Filed Jan 4, 2024 21:02 UTC |
DRISCOLL FREDERICK WDirector
|
GrantStock Option (right to buy) · Derivative | 24,400 | $0.00 Strike: $2.78 | $0.00 |
DisclosureSEC source: 0000950170-24-001829 · ownership.xml · derivative · entry 1 DRISCOLL FREDERICK W · CIK 0001129890 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,400 Underlying: Common Stock · 24,400 shares Expires 2034-01-01 F1 · shares: Represents a stock option award granted pursuant to the Issuer's Director Compensation Policy. F2 · derivative.exercise_date: This option was granted on January 2, 2024. The shares underlying the option are scheduled to vest in full on the anniversary date of the grant date. Read SEC document |
| January 02, 2024 Filed Jan 4, 2024 16:02 UTC |
Kiener Peter ADirector
|
GrantStock Option (right to buy) · Derivative | 24,400 | $0.00 Strike: $2.78 | $0.00 |
DisclosureSEC source: 0000950170-24-001830 · ownership.xml · derivative · entry 1 Kiener Peter A · CIK 0001328146 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,400 Underlying: Common Stock · 24,400 shares Expires 2034-01-01 F1 · shares: Represents a stock option award granted pursuant to the Issuer's Director Compensation Policy. F2 · derivative.exercise_date: This option was granted on January 2, 2024. The shares underlying the option are scheduled to vest in full on the anniversary date of the grant date. Read SEC document |
| January 02, 2024 Filed Jan 4, 2024 21:02 UTC |
Garzone PamelaDirector
|
GrantStock Option (right to buy) · Derivative | 24,400 | $0.00 Strike: $2.78 | $0.00 |
DisclosureSEC source: 0000950170-24-001833 · ownership.xml · derivative · entry 1 Garzone Pamela · CIK 0001974756 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,400 Underlying: Common Stock · 24,400 shares Expires 2034-01-01 F1 · shares: Represents a stock option award granted pursuant to the Issuer's Director Compensation Policy. F2 · derivative.exercise_date: This option was granted on January 2, 2024. The shares underlying the option are scheduled to vest in full on the anniversary date of the grant date. Read SEC document |
| January 02, 2024 Filed Jan 4, 2024 21:01 UTC |
Verheyen PatrickDirector
|
GrantStock Option (right to buy) · Derivative | 24,400 | $0.00 Strike: $2.78 | $0.00 |
DisclosureSEC source: 0000950170-24-001828 · ownership.xml · derivative · entry 1 Verheyen Patrick · CIK 0001972605 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,400 Underlying: Common Stock · 24,400 shares Expires 2034-01-01 F1 · shares: Represents a stock option award granted pursuant to the Issuer's Director Compensation Policy. F2 · derivative.exercise_date: This option was granted on January 2, 2024. The shares underlying the option are scheduled to vest in full on the anniversary date of the grant date. Read SEC document |
| January 02, 2024 Filed Jan 4, 2024 21:00 UTC |
Morich FrankDirector
|
GrantStock Option (right to buy) · Derivative | 24,400 | $0.00 Strike: $2.78 | $0.00 |
DisclosureSEC source: 0000950170-24-001827 · ownership.xml · derivative · entry 1 Morich Frank · CIK 0001748615 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,400 Underlying: Common Stock · 24,400 shares Expires 2034-01-01 F1 · shares: Represents a stock option award granted pursuant to the Issuer's Director Compensation Policy. F2 · derivative.exercise_date: This option was granted on January 2, 2024. The shares underlying the option are scheduled to vest in full on the anniversary date of the grant date. Read SEC document |
| August 25, 2023 Filed Aug 29, 2023 20:08 UTC |
Suri AnishPRESIDENT AND CSO
|
PurchaseCommon Stock | 4,000 | $2.76 | $11,040.00 |
DisclosureSEC source: 0001209191-23-047575 · doc4.xml · nonDerivative · entry 1 Suri Anish · CIK 0001739130 · PRESIDENT AND CSO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 135,638 Read SEC document |
| August 14, 2023 Filed Aug 16, 2023 16:07 UTC |
PASSERI DANIEL RDirector · CHIEF EXECUTIVE OFFICER
|
PurchaseCommon Stock | 3,000 | $2.86 | $8,580.00 |
DisclosureSEC source: 0001209191-23-046000 · doc4.xml · nonDerivative · entry 1 PASSERI DANIEL R · CIK 0001190121 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 134,578 Read SEC document |
| July 21, 2023 Filed Jul 25, 2023 16:27 UTC |
Sandercock ColinSVP, GENERAL COUNSEL
|
GrantStock Option (right to buy) · Derivative | 75,000 | $0.00 Strike: $4.20 | $0.00 |
DisclosureSEC source: 0001209191-23-043274 · doc4.xml · derivative · entry 1 Sandercock Colin · CIK 0001724870 · SVP, GENERAL COUNSEL 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 75,000 Underlying: Common Stock · 75,000 shares Expires 2033-07-20 F1 · derivative.exercise_date: This stock option grant becomes exercisable in twenty four equal monthly installments beginning on August 21, 2023. Read SEC document |
| July 21, 2023 Filed Jul 25, 2023 12:28 UTC |
PASSERI DANIEL RDirector · CHIEF EXECUTIVE OFFICER
|
GrantStock Option (right to buy) · Derivative | 450,000 | $0.00 Strike: $4.20 | $0.00 |
DisclosureSEC source: 0001209191-23-043276 · doc4.xml · derivative · entry 1 PASSERI DANIEL R · CIK 0001190121 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 450,000 Underlying: Common Stock · 450,000 shares Expires 2033-07-20 F1 · derivative.exercise_date: This stock option grant becomes exercisable in twenty four equal monthly installments beginning on August 21, 2023. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.